PHASIQ, Inc. provides immunoassay kits and custom assay development to research scientists investigating protein biomarker patterns for human health. The firm is working on an instrument designed to provide an ultra-specific diagnostic platform for detecting protein biomarkers in biological samples offering a micropatterned phase-separation technology that eliminates false signals in multiplex enzyme-linked immunosorbent assay. A start-up out of the University of Michigan with a focus on providing a cheaper, faster, and more accurate solution to test for multiple proteins on a single patient sample, the firm's device enables efficient, accurate, and inexpensive measurement of multiple health-indicator proteins via phase-separated droplets providing a cability to multiplex proteins not possible to measure simultaneously by other methods.
